Chris A. Rallis, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 269 shares at $8.25 ($2K) on 2023-11-20, disclosed to the SEC on 2023-11-20.
Scheduled sale ($2k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FENC | SELL | 2025-07-07 | $10K | — | Filing → |
| FENC | SELL | 2025-04-11 | $7K | — | Filing → |
| FENC | SELL | 2025-02-14 | $8K | — | Filing → |